The comparison of serum vaspin and visfatin concentrations in obese and normal weight women

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 9, Issue 4, 2015, Pages 320-323

  Saboori, S ^a,b   Hosseinzadeh Attar, M J ^a,b   Yousefi Rad, E ^a,b   Hosseini, M ^b   Mirzaei, K ^a,b   Ahmadivand, Z ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Obesity; Vaspin; Visfatin; Women

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN; SERINE PROTEINASE INHIBITOR; SERPINA12 PROTEIN, HUMAN;

ADULT; BLOOD; BODY MASS; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; RISK FACTOR; YOUNG ADULT;

ADULT; BIOMARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PROGNOSIS; RISK FACTORS; SERPINS; YOUNG ADULT;

EID: 84988452878     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2013.10.009     Document Type: Article

References (26)

1. H. Jin, B. Jiang, and J. Tang Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol Diabetes Res Clin Pract 79 2008 412 418
2. A. Fukuhara, M. Matsuda, and M. Nishizawa Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430
3. A. Rongvaux, R.J. Shea, and M.H. Mulks Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis Eur J Immunol 32 2002 3225 3234
4. K. Hida, J. Wada, and J. Eguchi Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity Proc Natl Acad Sci USA 102 2005 10610 10615
5. K. Kawano, T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi, and T. Natori Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain Diabetes Res Clin Pract 41 1992 1422 1428
6. N. Klöting, J. Berndt, and S. Kralisch Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes Biochem Biophys Res Commun 339 2006 430 436
7. M. Chen, F. Chung, and D. Chang Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 91 2006 295 299
8. D. Haider, G. Holzer, and G. Schaller The adipokine visfatin is markedly elevated in obese children J Pediatr Gastroenterol Nutr 43 2006 548 549
9. B. Zahorska-Markiewicz, M. Olszanecka-Glinianowicz, and J. Janowska Serum concentration of visfatin in obese women Metabolism 56 2007 1131 1134
10. M. Davutoglu, M. Ozkaya, and E. Guler Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric indices Swiss Med Wkly 139 2009 22 27
11. C. Pagano, C. Pilon, and M. Olivieri Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans J Clin Endocrinol Metab 91 2006 3165 3170
12. D.A. de Luis, M. Gonzalez Sagrado, R. Conde, R. Aller, O. Izaola, and E. Romero Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients Nutrition 24 2008 517 521
13. W.H. Sheu, T.M. Chang, and W.J. Lee Effect of weight loss on proinflammatory state of mononuclear cells in obese women Obesity 16 2008 1033 1038
14. G. Sun, J. Bishop, and S. Khalili Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men Am J Clin Nutr 85 2007 399 404
15. H.A. Rehiem, R.F. Abd Al Salam, T.H. Gado, and L.A. Rashed Visfatin G 948T polymorphism in Egyptian type 2 diabetes J Am Sci 6 2010 509 514
16. K. Takebayashi, M. Suetsugu, S. Wakabayashi, Y. Aso, and T. Inukai Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus Metabolism 56 2007 451 458
17. O. Sari, A. Tanuglo, and U. Aydogan Serum visfatin levels before and after levothyroxine treatment in cases with hypothyroidism and subclinical hypothyroidism and their relationships between the lipid levels Biomed Res 23 2012 55 59
18. D. Haider, G. Schaller, S. Kapiotis, C. Maier, A. Luger, and M. Wolzt The release of the adipocytokine visfatin is regulated by glucose and insulin Diabetologia 49 2006 1909 1914
19. E. García-Fuentes, J.M. García-Almeida, and J. García-Arnés Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass Obesity 15 2007 2391 2395
20. S. Kralisch, J. Klein, and U. Lossner Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes J Endocrinol 185 2005 1 8
21. S. Kralisch, J. Klein, and U. Lossner Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab 289 2005 586 590
22. S. Suleymanoglu, E. Tascilar, O. Pirgon, S. Tapan, C. Meral, and A. Abaci Vaspin and its correlation with insulin sensitivity indices in obese children Diabetes Res Clin Pract 84 2009 325 328
23. H.O. El-Mesallamy, D.H. Kassem, E. El-Demerdash, and A.I. Amin Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus Metabolism 60 2011 63 70
24. S. Zvonic, M. Lefevre, and G. Kilroy Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis Mol Cell Proteomics 6 2007 18 28
25. D.A. de Luis, R. Aller, and M. Gonzalez Sagrado Serum visfatin concentrations are related to dietary intake in obese patients Ann Nutr Metab 57 2010 265 270
26. J.O. Leite, R. DeOgburn, and J.C. Ratliff Low-carbohydrate diet disrupts the association between insulin resistance and weight gain Metabolism 58 2009 1116 1122